References
- Droge, W. (2001) "Free radicals in the physiological control of cell function", Physiol. Rev. 82, 47–95.
- Lander, H.M. (1997) "An essential role for free radicals and derived species in signal transduction", FASEB, J. 11, 118–124.
- Clerk, A., Fuller, S.J., Michael, A. and Sugden, P.H. (1998) "Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses", J. Biol. Chem. 273, 7228–7234.
- Irani, K. (2000) "Oxidant signaling in vascular cell growth, death and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signalling", Circ. Res. 87, 179–183.
- Ushio-Fukai, M., Alexander, R.W., Akers, M. and Griendling, K.K. (1998) "p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signalling pathways activated by angiotensin II: role in vascular smooth muscle cell hypertrophy", J. Biol. Chem. 273, 15022–15029.
- Frank, G.D., Eguchi, S., Yamakawa, T., Tanaka, S., Inagami, T. and Motley, E.D. (2000) "Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II", Endocrinology 141, 3120–3126.
- Schenk, H., Klein, M., Erdbrugger, W. and Droge, W. (1994) "Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NFkB and AP-1", Proc. Natl Acad. Sci., USA 91, 1672–1676.
- Meyer, M., Schreck, R. and Bauerle, P.A. (1993) "H202 and antioxidants have opposite effects on activation of NFkB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor", EMBO, J. 12, 2005–2015.
- Han, Y.J., Kwon, Y.G., Chung, H.T., Lee, 5.K., Simmons, R.L., Billiar, T.R. and Kim, Y.M. (2001) "Antioxidant enzymes suppress nitric oxide production through the inhibition of NF-KB activation: role of H202 and nitric oxide in inducible nitric oxide synthase expression in macrophages", Nitric Oxide 5, 504–513.
- Wang, Z., Castresana, M.R. and Newman, W.H. (2001) "Reactive oxygen and NF-kappaB in VEGF-induced migration of human vascular smooth muscle cells", Biochem. Biophys. Res. Commun. 285, 669–674.
- Lin, M.T., Yen, M.L., Lin, C.Y. and Kuo, M.L. (2003) "Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of src-dependent vascular endothelial cadherin tyrosine phos-phorylation", Mol. Pharmacol. 64, 1029–1036.
- Carmeliet, P. and Jain, R.K. (2000) "Angiogenesis in cancer and other diseases", Nature 407, 249–257.
- Morbidelli, L., Donnini, S. and Ziche, M. (2003) "Role of nitric oxide in the modulation of angiogenesis", Curr. Pharm. Des. 9, 521–530.
- Pipili-Synetos, E., Sakkoula, E., Haralambopoulos, G., Andriopoulos, P., Peristeris, P. and Maragoudakis, M.E. (1994) "Evidence that nitric oxide is an endogenous antiangiogenic inhibitor", Br. J. Pharmacol. 111, 894–902.
- Raychaudhury, A., Frischer, H. and Malic, A.B. (1996) "Inhibition of endothelial cell proliferation and bFGF-induced phenotypic modulation by nitric oxide", J. Cell. Biochem. 63, 125–134.
- Lelkes, P.I., Hahn, K.L., Sukovich, D.A., Karmiol, S. and Schmidt, D.H. (1998) "On the possible role of reactive oxygen species in angiogenesis", Adv. Exp. Med. Biol. 454, 295–310.
- Kuroki, M., Voest, E.E., Amano, S., Beerepoot, L.V., Takashima, S., Tolentino, M., Kim, R.Y., Rohan, R.M., Colby, K.A., Yeo, K.T. and Adamis, A.P. (1996) "Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo", J. Clin. Investig. 98, 1667–1675.
- Cho, M., Hunt, T.K. and Hussain, M.Z. (2001) "Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release", Am. J. Physiol. Heart Circ. Physiol. 280, H2357—H2363.
- Abid, M.R., Kachra, Z., Spokes, K.C. and Aird, W.C. (2000) "NADPH oxidase activity is required for endothelial cell proliferation and migration", FEBS Lett. 486, 252–256.
- Ushio-Fukai, M., Tang, Y, Fukai, T., Dikalov, S.I., Ma, Y., Fujimoto, M., Quinn, M.T., Pagano, P.J., Johnson, C. and Alexander, R.W. (2002) "Novel role of gp91Ph"-contain-ing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis", Circ. Res. 91, 1160–1167.
- Hatziapostolou, M., Katsoris, P. and Papadimitriou, E. (2003) "Different inhibitors of plasmin differentially affect angio-statin production and angiogenesis", Eur. J. Pharmacol. 460, 1–8.
- Thompson, W.D. and Kazmi, M.A. (1989) "Angiogenic stimulation compared with angiogenic reaction to injury: distinction by focal and general application of trypsin to the chick chorioallantoic membrane", Br. J. Exp. Pathol. 70, 627–635.
- Hadjimichael, C., Kardamakis, D., Demopoulos, J. and Papaioannou, S. (1999) "A modified chorioallantoic mem-brane assay for irradiation doseresponse studies of angio-genesis and involvement of nitric oxide", J. BUON 4,393–398.
- Giannopoulou, E., Katsoris, P., Polytarchou, C. and Papadimitriou, E. (2002) "Nitration of cytoskeletal proteins in the chicken embryo chorioallantoic membrane", Arch. Biochem. Biophys. 400, 188–198.
- Bradford, M.M. (1976) "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding", Anal. Biochem. 72,248–254.
- Pipili-Synetos, E., Kritikou, S., Papadimitriou, E., Athanassiadou, A., Flordellis, C. and Maragoudakis, M.E. (2000) "Nitric oxide synthase expression, enzyme activity and NO production during angiogenesis in the chicken chorioallantoic membrane", Br. J. Pharmacol. 129, 207–213.
- Giannopoulou, E., Katsoris, P., Kardamakis, D. and Papadimitriou, E. (2003) "Amifostine inhibits angiogenesis in vivo", J. Pharmacol. Exp. Therap. 304, 729–737.
- Shono, T., Ono, M., lzumi, H., Jimi, S.I., Matsushima, K., Okamoto, T., Kohno, K. and Kuwano, M. (1996) "Involvement of the transcription factor NF-KB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress", Mol. Cell. Biol. 16, 4231–4239.
- Maulik, N. and Das, D.K. (2002) "Redox signaling in vascular angiogenesis", Free Radic. Biol. Med. 8, 1047–1060.
- Maulik, N. (2002) "Redox signalling of angiogenesis", Antioxid. Redox Signal. 4, 805–815.
- Ribatti, D., Urbinati, C., Nico, B., Rusnati, M., Roncali, L. and Presta, M. (1995) "Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane", Dev. Biol. 170, 39–49.
- Wu, F., Tyml, K. and Wilson, J.X. (2002) "Ascorbate inhibits iNOS expression in endotoxin- and IFN•y-stimulated rat skeletal muscle endothelial cells", FEBS Lett. 520(1995), 122–126.
- Chiarugi, V, Magnelli, L. and Gallo, 0. (1998) "COX-2, iNOS and p53 as play-makers of tumor angiogenesis", Int. J. Mol. Med. 2, 715–719.
- Cianchi, F., Cortesini, C., Fantappie, 0., Messerini, L., Schiavone, N., Vannacci, A., Nistri, S., Sardi, I., Baroni, G., Marzocca, C., Perna, F., Mazzanti, R., Bechi, P. and Masini, E. (2003) "Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis", Am. J. Pathol. 162, 793–801.
- Babior, B.M. (2000) "The NADPH oxidase of endothelial cells", IUBMB Life 50, 267–269.
- Radomski, M.W., Palmer, R.M.J. and Moncada, S. (1990) "Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells", Proc. Natl Acad. Sci., USA 87, 10043–10047.
- Matsumura, M., Kakishita, H., Suzuki, M., Banba, N. and Hattori, Y. (2001) "Dexamethasone suppresses iNOS gene expression by inhibiting Nf-KappaB in vascular smooth muscle cells", Life Sci. 69, 1067–1077.
- Ehsan, A., Sommer, F., Schmidt, A., Klotz, T., Koslowski, J., Niggemann, S., Jacobs, G., Engelmarm, U., Addicks, K. and Bloch, W. (2002) "Nitric oxide pathways in human bladder carcinoma. The distribution of nitric oxide synthases, soluble guanylyl cyclase, cyclic guanosine monophosphate and nitrotyrosine", Cancer 95, 2293–2301.